|
E-mail this page to a friend!
Only Half of Men with Prostate Cancer Consider
Chemotherapy
Nearly 65% believe impact on quality of life
outweighs benefit
Sept. 8, 2005 - A new survey released today showed
only half (50 percent) of men who suffer from late-stage prostate cancer
would consider chemotherapy as a treatment option, the only available
treatment to delay progression of prostate cancer for these patients.
While patients understand that chemotherapy is an effective option and
recognize its value in prolonging survival, nearly two-thirds of
patients (65 percent) believe the impact on quality of life outweighs
its benefit.
Prostate cancer primarily strikes male senior citizens - 65 and older -
and is the second leading cancer killer of men.
| |
Related Stories |
|
| |
Prostate Cancer Growth Slowed Dramatically by
Vitamin D with Pain Killers
Sept. 1, 2005 – There is new hope in the battle
against prostate cancer, which primarily strikes male senior citizens
and is the second leading cancer killer of men. It was announced today,
however, that researchers have stopped up to 70 percent of the cancer
cell growth by combining a form of vitamin D with low doses of
non-steroidal anti-inflammatory drugs.
Read more...
Diet and Exercise Work in Slowing Prostate Cancer
Two thirds of prostate cancers found in senior
citizens
Aug. 11, 2005 - Men with early stage prostate
cancer – the second leading cause of cancer death in men - who make
intensive changes in diet and lifestyle may stop or perhaps even reverse
the progression of their illness, according to a new study. The chance
of having prostate cancer increases rapidly after age 50. About two
thirds of all prostate cancers are diagnosed in senior men over the age
of 65. It is still unclear why this increase with age occurs, according
to the American Cancer Society.
Read more...
Prostate Cancer: More Aggressive Detection Needed,
New EPCA Marker May Help - May 16, 2005
Finasteride Will Save Lives of Prostate Cancer
Victims, Says New Study - Feb. 2005
|
|
The findings, released by the prostate cancer
advocate group Us TOO International Prostate Cancer Education & Support
Network, showed nearly two-thirds of patients, caregivers and physicians
surveyed were dissatisfied with the current treatment options for
advanced prostate cancer.
Currently, there are few options for men with
late-stage prostate cancer, either chemotherapy or supportive care. In
the last stages of the disease, the majority of men will experience
significant bone pain, the most common site where the cancer spreads. Of
the late-stage patients surveyed bone pain is the number one concern.
Two-thirds (67 percent) of these patients surveyed feared they will feel
pain as their prostate cancer progresses and half (47 percent) of those
who experienced bone pain report that they feel bone pain all of the
time or everyday.
"Men with late-stage disease need more options.
These men and their families shouldn't have to compromise their quality
of lives," said Thomas Kirk, president and CEO of Us TOO International.
"We need better treatments that fight this disease, address the most
painful symptoms, and lessen the side effects of treatment."
The more than 500 prostate cancer patients,
caregivers and physicians surveyed by Us TOO is just one of several new
reports highlighting the quality of life choices men face when fighting
prostate cancer. In the latest patient edition of the "Report to the
Nation on Prostate Cancer: A Guide for Men and Their Families," the
Prostate Cancer Foundation offers a comprehensive look at the many
challenges prostate cancer patients will encounter when facing this
devastating disease. An entire chapter of the publication is dedicated
to explaining why and how different chemotherapy drugs are used, and the
principles of dealing with side effects. The Report is being released to
patients and caregivers today and is being made available at
http://www.prostatecancerfoundation.org .
"During the next 10 years, the number of men
diagnosed with prostate cancer is expected to increase by 40 percent
from approximately 230,000 to more than 300,000 a year. Furthermore,
it's expected that during the next 10 years, the number of prostate
cancer deaths could rise from 30,000 to 50,000 per year," said Jim
Kiefert, chairman of the Us TOO International Board of Directors. "As
more men continue to be diagnosed with advanced prostate cancer, the
need for new treatment options will be critical."
About Prostate Cancer
One in six American men will develop prostate
cancer in the course of his lifetime, making it the most commonly
diagnosed non-skin cancer in the United States. Every year more than
230,000 men are diagnosed with the disease, and in 2005 more than 30,000
will die from prostate cancer. Unfortunately, early prostate cancer has
few recognizable symptoms, however if detected early by a physician,
prostate cancer is often treatable.
Click to More Senior News on the
Front Page
Copyright: SeniorJournal.com |
